Benzinga | Jul 27, 2020 12:03PM EDT

Dawson James Initiates Coverage On OncoSec Medical with Buy Rating, Announces Price Target of $10

Dawson James analyst Jason Kolbert initiates coverage on OncoSec Medical (NASDAQ:ONCS) with a Buy rating and announces Price Target of $10.